« Back to Record
Citation APA

Baron, F., Theunissen, K., Willems, E., Emonds, M. P., De Becker, A., Beguin, Y., Zachée, P., Maertens, J., Kerre, T., Ory, A., Seidel, L., Graux, C., Lewalle, P., & Van Gelder, M. (2015). Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: A phase II randomized study from the belgian hematological society. Journal of Hematology & Oncology, 8(1), 4. doi:10.1186/s13045-014-0098-9


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/205806

Baron, F., Theunissen, K., Willems, E., Emonds, M. P., De Becker, A., Beguin, Y., Zachée, P., Maertens, J., Kerre, T., Ory, A., Seidel, L., Graux, C., Lewalle, P., & Van Gelder, M. (2015). Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: A phase II randomized study from the belgian hematological society. Journal of Hematology & Oncology, 8(1), 4. doi:10.1186/s13045-014-0098-9